Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Di Wu, Mengjie Si, Hui-Yi Xue & Ho-Lun Wong. (2017) Nanomedicine applications in the treatment of breast cancer: current state of the art. International Journal of Nanomedicine 12, pages 5879-5892.
Read now
Read now
Yannan Nancy Dou, Michael Dunne, Huang Huang, Trevor Mckee, Martin C. Chang, David A. Jaffray & Christine Allen. (2016) Thermosensitive liposomal cisplatin in combination with local hyperthermia results in tumor growth delay and changes in tumor microenvironment in xenograft models of lung carcinoma*. Journal of Drug Targeting 24:9, pages 865-877.
Read now
Read now
Gina Song, Huali Wu, Keisuke Yoshino & William C. Zamboni. (2012) Factors affecting the pharmacokinetics and pharmacodynamics of liposomal drugs. Journal of Liposome Research 22:3, pages 177-192.
Read now
Read now
Teni Boulikas. (2009) Clinical overview on Lipoplatin™: a successful liposomal formulation of cisplatin. Expert Opinion on Investigational Drugs 18:8, pages 1197-1218.
Read now
Read now
Articles from other publishers (20)
Piao Jiang, Bin Liang, Zhen Zhang, Bing Fan, Lin Zeng, Zhiyong Zhou, Zhifang Mao, Quan Xu, Weirong Yao & Qinglin Shen. (2023) New insights into nanosystems for non-small-cell lung cancer: diagnosis and treatment. RSC Advances 13:28, pages 19540-19564.
Crossref
Crossref
Ana I. Fraguas-Sánchez, Cristina Martín-Sabroso, Irene Lozza & Ana I. Torres-Suárez. 2022. Handbook of Cancer and Immunology. Handbook of Cancer and Immunology
1
37
.
Filipa Canão, Helena Ferreira & Nuno M. Neves. (2022) Liposomal formulations for lung cancer treatment in the last two decades: a systematic review. Journal of Cancer Research and Clinical Oncology 148:9, pages 2375-2386.
Crossref
Crossref
Tugce Boztepe, Guillermo R. Castro & Ignacio E. León. (2021) Lipid, polymeric, inorganic-based drug delivery applications for platinum-based anticancer drugs. International Journal of Pharmaceutics 605, pages 120788.
Crossref
Crossref
Panpan Lv, Shuli Man, Lu Xie, Long Ma & Wenyuan Gao. (2021) Pathogenesis and therapeutic strategy in platinum resistance lung cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1876:1, pages 188577.
Crossref
Crossref
Isabella Pötsch, Dina Baier, Bernhard K. Keppler & Walter Berger. 2019. Metal-based Anticancer Agents. Metal-based Anticancer Agents
308
347
.
Bei Xu, Min Zeng, Jiawei Zeng, Jiafu Feng & Lin Yu. (2018) Meta-analysis of clinical trials comparing the efficacy and safety of liposomal cisplatin versus conventional nonliposomal cisplatin in nonsmall cell lung cancer (NSCLC) and squamous cell carcinoma of the head and neck (SCCHN). Medicine 97:46, pages e13169.
Crossref
Crossref
Li Gu, Zhou J. Deng, Sweta Roy & Paula T. Hammond. (2017) A Combination RNAi-Chemotherapy Layer-by-Layer Nanoparticle for Systemic Targeting of KRAS/P53 with Cisplatin to Treat Non–Small Cell Lung Cancer. Clinical Cancer Research 23:23, pages 7312-7323.
Crossref
Crossref
Marzia Marciello, Juan Pellico, Irene Fernandez-Barahona, Fernando Herranz, Jesus Ruiz-Cabello & Marco Filice. (2016) Recent advances in the preparation and application of multifunctional iron oxide and liposome-based nanosystems for multimodal diagnosis and therapy. Interface Focus 6:6, pages 20160055.
Crossref
Crossref
Xiaopin Duan, Chunbai He, Stephen J. Kron & Wenbin Lin. (2016) Nanoparticle formulations of cisplatin for cancer therapy. WIREs Nanomedicine and Nanobiotechnology 8:5, pages 776-791.
Crossref
Crossref
Bhushan S. Pattni, Vladimir V. Chupin & Vladimir P. Torchilin. (2015) New Developments in Liposomal Drug Delivery. Chemical Reviews 115:19, pages 10938-10966.
Crossref
Crossref
Anish Babu, Narsireddy Amreddy & Rajagopal Ramesh. (2015) Nanoparticle-based cisplatin therapy for cancer. Therapeutic Delivery 6:2, pages 115-119.
Crossref
Crossref
Yannan N. Dou, Jinzi Zheng, Warren D. Foltz, Robert Weersink, Naz Chaudary, David A. Jaffray & Christine Allen. (2014) Heat-activated thermosensitive liposomal cisplatin (HTLC) results in effective growth delay of cervical carcinoma in mice. Journal of Controlled Release 178, pages 69-78.
Crossref
Crossref
Andrew Z. WangRobert Langer & Omid C. Farokhzad. (2012) Nanoparticle Delivery of Cancer Drugs. Annual Review of Medicine 63:1, pages 185-198.
Crossref
Crossref
Manuela Fantini, Lorenzo Gianni, Carlotta Santelmo, Fabrizio Drudi, Cinzia Castellani, Alessandra Affatato, Mario Nicolini & Alberto Ravaioli. (2011) Lipoplatin Treatment in Lung and Breast Cancer. Chemotherapy Research and Practice 2011, pages 1-7.
Crossref
Crossref
Feng Yang, Chen Jin, Yongjian Jiang, Ji Li, Yang Di, Quanxing Ni & Deliang Fu. (2011) Liposome based delivery systems in pancreatic cancer treatment: From bench to bedside. Cancer Treatment Reviews 37:8, pages 633-642.
Crossref
Crossref
Anna Giulia Cattaneo, Rosalba Gornati, Enrico Sabbioni, Maurizio Chiriva-Internati, Everardo Cobos, Marjorie R. Jenkins & Giovanni Bernardini. (2010) Nanotechnology and human health: risks and benefits. Journal of Applied Toxicology 30:8, pages 730-744.
Crossref
Crossref
David J. Stewart. (2010) Tumor and host factors that may limit efficacy of chemotherapy in non-small cell and small cell lung cancer. Critical Reviews in Oncology/Hematology 75:3, pages 173-234.
Crossref
Crossref
Nial J. Wheate, Shonagh Walker, Gemma E. Craig & Rabbab Oun. (2010) The status of platinum anticancer drugs in the clinic and in clinical trials. Dalton Transactions 39:35, pages 8113.
Crossref
Crossref
Giovanni Bernardini, Anna Giulia Cattaneo, Enrico Sabbioni, Mario Di Gioacchino, Maurizio Chiriva‐Internati & Rosalba Gornati. 2009. General, Applied and Systems Toxicology. General, Applied and Systems Toxicology.